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Background: Frank-ter Haar syndrome is a rare disorder associated with skeletal, cardiac, ocular and craniofacial
features including hypertelorism and brachycephaly. The most common underlying genetic defect in Frank-ter Haar
syndrome appears to be a mutation in the SH3PXD2B gene on chromosome 5q35.1. Craniosynostosis, or premature
fusion of the calvarial sutures, has not previously been described in Frank-ter Haar syndrome.
Case presentation: We present a family of three affected siblings born to consanguineous parents with clinical
features in keeping with a diagnosis of Frank-ter Haar syndrome. All three siblings have a novel mutation caused by
the deletion of exon 13 of the SH3PXD2B gene. Two of the three siblings also have non-scaphocephalic sagittal
synostosis associated with raised intracranial pressure.
Conclusion: The clinical features of craniosynostosis and raised intracranial pressure in this family with a confirmed
diagnosis of Frank-ter Haar syndrome expand the clinical spectrum of the disease. The abnormal cranial proportions
in a mouse model of the disease suggests that the association is not coincidental. The possibility of
craniosynostosis should be considered in individuals with a suspected diagnosis of Frank-ter Haar syndrome.
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Frank-ter Haar syndrome is a rare disorder comprising
cardiovascular, skeletal and craniofacial anomalies in-
cluding hypertelorism, brachycephaly and a wide anter-
ior fontanelle [1]. The ‘ter Haar’ syndrome was initially
described in three related children, all of whom devel-
oped severe cardiovascular complications [2,3]. These
patients appeared to share many of the craniofacial and
skeletal features normally associated with Melnick-
Needles Syndrome, an X-linked congenital disorder of
skeletal dysplasia. However the autosomal recessive pat-
tern of inheritance and congenital cardiac defects distin-
guished the syndrome as a separate entity [4,5]. The
condition affecting this subgroup of patients was
renamed Frank-ter Haar syndrome following the realisa-
tion that ter Haar’s three patients shared many of the
features described previously by Frank in an 18 month* Correspondence: davidjohnson@doctors.org.uk
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reproduction in any medium, provided the orold female with megalocornea, skeletal dysplasia and de-
velopmental delay [1,6].
A genetic basis for Frank-ter Haar syndrome has re-
cently been established through homozygosity mapping
studies in patients from 12 affected families, identifying
homozygous mutations in the SH3PXD2B gene on
chromosome 5q35.1 as the most common cause [7]. The
analysis of patients from 13 families identified 4 different
intragenic mutations, and one complete deletion of
SH3PXD2B, accounting for the phenotype in 7 of the
families [7]. Clinical features characterising this group of
mutation positive patients include brachydactyly megalo-
cornea, hypertelorism, a prominent forehead, brachy-
cephaly, a wide anterior fontanelle, micrognathia, a
broad mouth and full cheeks [7]. Sh3pxd2b null mice ap-
pear to share many of the skeletal, craniofacial, cardiac
and ocular defects described in Frank-ter Haar syn-
drome, supporting the link between this gene and the
syndrome [7].
The craniofacial features of Frank-ter Haar syndrome
are numerous however to our knowledge craniosynostosis
has not been reported previously. Craniosynostosis refersl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sutures, affecting 1 in 2500 individuals [8]. The calvarial
sutures arise where cranial ossification centres meet at ap-
proximately 18 weeks of embryonic development. From
this stage onwards further skull growth is appositional,
and deposition of new mineralised bone matrix occurs
along the margins of the sutures [8]. Synchronised closure
of these sutures during the postnatal period allows the cal-
varium to achieve its full size and shape, facilitating nor-
mal expansion and development of the underlying brain
[9]. Growth restriction along a given margin may result in
compensatory, excessive growth at other sutures leading
to skull deformity [10]. Furthermore as the brain con-
tinues to develop and expand within a limited cranial cap-
acity, raised intracranial pressure (ICP) may complicate
craniosynostosis, with potential neurodevelopmental con-
sequences [11].
Here we describe three siblings with the Frank-ter
Haar syndrome phenotype, all of whom are homozygous
for a complete deletion of exon 13 of the SH3PXD2B
gene. They demonstrate many of the classic features
associated with Frank-ter Haar syndrome, however two
of them also have presented with non-scaphocephalic sa-
gittal synostosis complicated by raised ICP.
Case presentation
We present a family of four children born to consan-
guineous (first cousin) parents originating from Kashmir,
Pakistan. Three siblings (two males and one female) have
Frank-ter Haar syndrome (Table 1, Figure 1) confirmed
by genetic analysis. The youngest male sibling appears to
be unaffected.
Patient 1
This male patient was the firstborn child, delivered by
caesarean section for macrocephaly and cephalopelvic
disproportion. Hypertelorism and dysmorphia were
noted at birth, without evidence of fetal head constraint.
He was referred to the Plastic Surgery Department for
severe hypertelorism and forehead bossing. On examin-
ation at 20 months the head circumference was 49 cm
(>99.6th centile), with marked hypertelorism, frontal
skull bossing, a wide open anterior fontanelle, and a per-
sistent metopic suture. The cephalic index was 86% con-
firming the clinical appearance of mild brachycephaly
(normal range 76-85%). Limb examination revealed se-
vere bilateral cavo varus of the feet and bilateral
metacarpo-phalangeal (MCP) joint hyperextension and
contractures.
CT head and 3D studies at age 1 year and 10 months
demonstrated patency of the major cranial sutures and
confirmed the clinical findings of hypertelorism and an
open anterior fontanelle. Surgical correction for bilateral
cavo varus at age 7 years and 4 months was complicatedby cardiopulmonary decompensation, pulmonary hyper-
tension and a marked oxygen requirement during the
post-operative period. Echocardiography demonstrated
severe mitral valve prolapse with moderate mitral regur-
gitation, mild tricuspid valve prolapse and mild aortic re-
gurgitation, however ventricular function was good at
the time.
The diagnosis of Frank-ter Haar syndrome was initially
suspected at the age of 18 months. The G-banded karyo-
type was normal (46,XY). Alternative clinical diagnoses
considered included Winchester syndrome and geleo-
physic dysplasia, but genetic testing for these disorders
was normal. The diagnosis was confirmed following the
identification of the SH3PXD2B mutation at age 12 years
and 4 months (Figure 2, Figure 3).
The mitral valve function subsequently deteriorated
resulting in ventricular dilatation and requiring mitral
valve repair at 12 years and 5 months. Examination at age
12 years and 11 months revealed a progressive lower limb
oedema, which had been developing over a 2 year period,
and was initially suspected to be a complication of his
cardiac condition. Originally affecting the right leg only, it
had progressed to involve the left groin, left leg and geni-
talia, and appeared to be lymphatic in origin. Lymphos-
cintigraphy studies at age 13 years and 10 months
demonstrated profound lymphatic abnormalities in both
lower legs and functional hypoplasia of the main draining
lymphatics.
This patient has a left-sided astigmatism and meibo-
mian gland dysfunction; however he does not have any
of the ocular complications classically associated with
Frank-ter Haar syndrome, such as megalocornea and
glaucoma [7,16]. Intraocular pressures have been within
the normal range, without clinical evidence of glaucoma.
He has been attending a mainstream school with learn-
ing support, and is under occupational therapy for diffi-
culties with fine motor skills, washing and dressing as a
result of the severe hand contractures and deformity.
Patient 2
This is the second affected sibling in the family, deliv-
ered by caesarean section for maternal proteinuria with-
out evidence of fetal head constraint. Facial features
including hypertelorism were noticed at birth. Examin-
ation on presentation to the craniofacial department at
age 6 years and 6 months demonstrated hypertelorism,
brachycephaly (cephalic index 89%), a flat nasal bridge,
prominent ears, a class III malocclusion and hypoplastic
teeth. Her fingers and toes appeared shortened and exo-
stoses on the dorsal aspect of the radius and ulna were
visible on examination of the arms.
CT head and 3D studies were carried out at age 6 years
and 10 months to further delineate the craniofacial features.
This demonstrated sagittal synostosis, however the skull
Table 1 Comparison of clinical features in patients 1–3 with previous cases with proven SH3PXD2B mutations




Gender M F M M:F 8:2
Consanguinity + + + 9/10
Craniofacial
Prominent forehead + + + 10/10
Hypertelorism + + + 9/9
Brachycephaly + + + 10/10
Wide anterior fontanelle + - + 10/10
Prominent ears + + + 5/7
Flat nasal bridge + + +
Micrognathia + - - 9/10
Class III malocclusion - + + †
Anterior open bite - - + †
Open metopic suture + - + †
Sagittal synostosis - + + †
Raised intracranial pressure - + + †
Hypoplasia of teeth + + +
Broad mouth + + + 10/10
Broad alveolar ridges NR NR NR 6/8
Anteverted nostrils - - - 6/9
Full cheeks + + + 10/10
Skeletal
Talipes + - + 5/8
Size discrepancy in feet - + - †
Exostoses + + - †
Subcutaneous nodules + + - †
Contractures/flexion deformity fingers/clawing + - - 3/10
Short hands/digits, brachydactyly + + + 10/10
Kyphosis - - + 5/8
Bowing of long bones NT NT NT 7/10
Prominent coccyx + - - 8/10
Cardiac
Aortic regurgitation/prolapse AVR AVR - 1/6
Tricuspid regurgitation + - -
Mitral valve prolapse/regurgitation MVP/MVR MVP/MVR MVR 3/6
Ventricular septal defect - - - 5/7
Double right outlet - - - 2/3
Ocular
Megalocornea - - - 9/9
Congenital glaucoma/raised IOP - - -
Bendon et al. BMC Medical Genetics 2012, 13:104 Page 3 of 8
http://www.biomedcentral.com/1471-2350/13/104
Table 1 Comparison of clinical features in patients 1–3 with previous cases with proven SH3PXD2B mutations
(Continued)
Other
Recurrent UTIs/duplex system NT + NT
Bilateral lymphoedema legs + - - †
Comparison is made with features in other previously-reported confirmed cases of Frank-ter Haar syndrome with known SH3PXD2B mutations [7].
† − Features not described in any previous reports or Frank-ter Haar syndrome, regardless of whether or not genetic analysis was performed to confirm the
diagnosis [1-3,5,7,12-15].
NR - not recorded.
NT - not tested.
AVR - aortic valve regurgitation.
MVR - mitral valve regurgitation.
MVP - mitral valve prolapse.
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chycephalic in keeping with the clinical examination find-
ings. There was evidence of limited space within the
supratentorial compartment, and small ventricles. Although
neurological development had previously been withinFigure 1 A-D: Patient 1. A: Antero-posterior (AP) view showing facial feat
and micrognathia. C: X-ray (XR) right radius/ulna showing broad appearanc
thirds. D: XR left hand showing crowding of the carpal bones, broad metac
PIP joints. E-G: Patient 2. E: AP view showing facial features including hyp
showing absence of the sagittal suture. H-J: Patient 3. H: AP view showing
malocclusion and brachycephaly. J: 3D CT scan showing absence of the sanormal limits, difficulties with literacy and recurrent head-
aches were reported at this time, also suggestive of raised
ICP. ICP monitoring (Codman Microsensor, Codman and
Shurtleff Inc., Raynham, Mass.) demonstrated elevated
pressures with a mean of 22 mmHg and 5 significantures including hypertelorism. B: Lateral view showing brachycephaly
e of the radius at the junction between the proximal and middle
arpals, proximal and middle phalanges, and flexion at the MCP and
ertelorism. F: Lateral view showing brachycephaly. G: 3D CT scan
facial features including hypertelorism. I: Lateral view showing class III
gittal suture.
Figure 2 Genome and sequence context of deletion in SH3PXD2B. The upper panel shows a schematic representation (not to scale) of
SH3PXD2B around the deleted region. Exons are shown as rectangles with coding sequence filled black and the 30 UTR unfilled. Affected
individuals were homozygous for a 7,625 bp deletion (double-headed red arrow). The breakpoint (dotted red lines) occurred at the position
shown in the sequence chromatogram from patient 2, with an ambiguity of one nucleotide because a cytosine is located at both breakpoints.
The lower panel shows the results of PCR with the primer pairs indicated. Individuals homozygous for the deletion failed to amplify using primer
pair 12F/13-8R (upper gel image, 2,268 bp product); all family members yielded a truncated product using primer pair 12F/13-7R (lower gel
image; non-deleted product would be 11,464 bp) indicating that unaffected family members are heterozygous for the deletion. C: control DNA
from an unaffected, unrelated individual. N: negative control. The hg19 co-ordinates of the deleted region are chr5:171,763,754-171,771,378.
Figure 3 Schematic plan of SH3PXD2B (TKS4) protein showing all mutations identified to date and their location in relation to domains
defined by PROSITE (prosite.expasy.org). Note the extent of the deletion identified in this family. A deletion of the entire encoding SH3PXD2B
gene has also been reported in another affected family [7].
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undertaken. She made a good post-operative recovery, and
the headaches subsequently resolved.
This sibling has also developed cardiac complications
but has been less severely affected than her older sib-
ling. Echocardiography at age 7 years and 6 months
demonstrated mild-moderate mitral regurgitation with
mitral valve prolapse, and minimal aortic regurgitation.
Left ventricular function is currently stable. The diag-
nosis of Frank-ter Haar syndrome was made at age
7 years and 7 months following genetic analysis of the
family (Figure 2).
This patient has not developed any of the ocular com-
plications classically associated with Frank-ter Haar syn-
drome and intraocular pressures and appearance of the
retina have been within normal limits. She has been
attending a mainstream school, but has experienced
some difficulties with literacy.Patient 3
Patient 3 is the younger affected male sibling. He was
delivered by caesarean section following a normal preg-
nancy, without evidence of fetal head constraint. Facial
features in keeping with Frank-ter Haar syndrome were
noticed soon after birth including hypertelorism, a broad
forehead, wide anterior fontanelle, brachycephaly and
prominent ears. The diagnosis of Frank-ter Haar syn-
drome was made at age 6 years and 5 months, following
genetic analysis of the family (Figure 2).
CT head and 3D studies were performed at age 6 years
and 9 months following the outcome of these investigations
in Patient 2. Evidence of sagittal synostosis without scapho-
cephaly, a flattened occiput and shortened AP diameter
were identified on CT. There was hypoplasia of the inferior
vermis but an otherwise normal appearance of the brain.
Given the history of raised ICP in his sibling, ICP monitor-
ing was undertaken at age 6 years and 10 months, demon-
strating a mean pressure of 10 mmHg but 7 B waves,
indicating raised ICP.
Examination at age 7 years and 1 month demonstrated an
anterior open bite, class III malocclusion, hypoplasic teeth
and skeletal features including short fingers and toes, and a
mild positional talipes. The cephalic index was 88% in keep-
ing with the clinical appearance of brachycephaly. Calvarial
expansion was performed at age 7 years and 7 months.
Cardiac complications have also been documented, but
have been less severe than the other affected siblings, with
evidence of mild mitral regurgitation on echocardiog-
raphy. No ocular complications have been reported, and
intraocular pressures have been within the normal range.
He has required some learning support for literacy and
numeracy, but developmental progress and performance
at school have been within normal limits.Genetic analysis
We genotyped DNA samples from three affected patients,
one unaffected sibling and their parents using the Affyme-
trix GeneChipW Human Mapping 250K Sty Array. Linkage
analysis was performed assuming autosomal recessive in-
heritance, full penetrance, consanguinity and a disease al-
lele frequency of 0.0001. Multipoint LOD scores were
calculated using the program ALLEGRO [17]. We identi-
fied three regions of shared homozygosity on chromo-
somes 5 (150943995–173861414; hg18 coordinates), 8
(134041593–146264218) and 12 (115552170–123960781).
Following the identification of mutations in Frank-ter
Haar syndrome [7], it was noted that the region of homo-
zygosity on chromosome 5 included the SH3PXD2B gene.
All coding exons of SH3PXD2B were therefore PCR ampli-
fied in samples from the family (primer sequences available
on request). As exon 13 failed to amplify (using pri-
mers 13F, 50-AACATCTCCATTGGTGGTCC-30 and 13R,
50-GATGTGTTTGGCTGGCATC-30, positions of primers
are shown in Figure 2) in the affected individuals, an alter-
native primer pair (13-2F, 5 0-CATGTAAGATATTCCCGG
AACATGGT-3 0; 13-2R, 50-CCCCATGTCATTTTTCAGC
TGGAACA-30) was designed to rule out the possibility of a
SNP underlying the primer and preventing annealing. This
also failed to amplify in the 3 affected individuals, confirm-
ing a homozygous deletion of exon 13 of SH3PXD2B.
Further primer pairs were designed throughout the 30
untranslated region (UTR) to identify the extent of the
deletion (primer sequences available on request), a primer
pair near the end of the 30 UTR successfully amplified in
the affected individuals (13-7F, 50-TACCTTACATCCCA
GGGCAAACGGACAGCT-30; 13-7R, 50-GCGTGGCCT
TGTGGCAGAGGTTTAAAATGAC-30), the reverse pri-
mer of which was then used in a long PCR with the
12F primer (50-AATCCAACTAGGTCCCCAGC-30). This
yielded a truncated product of ~3.5 kb rather than the
normal 11,464 kb, which was sequenced to identify the
exact breakpoint. All family members produced this
smaller PCR product, demonstrating that unaffected
members are heterozygous carriers of the allele bearing
the deletion, which preferentially amplifies during PCR.
The non-deleted allele was demonstrated by PCR be-
tween 12F and 13-8R (50-CATAACACATCCTGAAGA
TAAACAGCCTAGACA-30). The complete deletion of
the coding part of exon 13 is predicted to abolish over
half of the protein, including the SH3 domains and a
proline-rich domain (Figure 3).
Conclusions
Frank-ter Haar syndrome is a rare, autosomal recessive
disorder. We present three siblings born to consanguin-
eous parents, who are homozygous for a deletion of
exon 13 of the SH3PXD2B gene. These three children
share many of the characteristic physical features of the
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lings also developed non-scaphocephalic sagittal synos-
tosis, both cases being complicated by raised ICP.
Craniosynostosis and raised ICP have not been described
in previous reports of Frank ter-Haar syndrome.
The sagittal suture is involved in 50-60% of cases of cra-
niosynostosis, and is therefore the most common suture to
be synostosed [8,10]. Familial or genetic factors are less sig-
nificant in sagittal synostosis than in other forms of cranio-
synostosis. In a large study of over 500 patients with
isolated sagittal synostosis familial factors were identified
in only 6% [18]. Most such cases are likely to be multifac-
torial, as causative genetic mutations are only rarely identi-
fied [19-21]. In comparison genetic factors comprising
chromosomal abnormalities and gene mutations appear to
account for at least 21% of cases of craniosynostosis overall
[22]. Intrauterine fetal head constraint has been implicated
as an important causative factor in sagittal synostosis [23],
however to our knowledge neither of our two Frank-ter
Haar siblings with sagittal synostosis had a history of intra-
uterine fetal head constraint.
It is widely acknowledged that premature fusion of the
calvarial sutures may restrict normal growth and devel-
opment of the underlying brain especially in syndromic
cases. This can be complicated by raised ICP [10].
Raised ICP may be defined as an elevated baseline ≥15
mmHg, or >3 B waves (levels of 20–50 mmHg lasting
5–10 minutes before returning to baseline) in a 24 hour
period [24,25]. In early studies, raised ICP was demon-
strated in only 14% of cases of single suture synostosis
but affected almost 50% of cases involving more than
one suture [11]. The discovery of raised ICP in both of
our patients with Frank-ter Haar syndrome and sagittal
synostosis is unusual. Scaphocephaly is a predictable
consequence of sagittal synostosis and refers to a boat-
shaped skull deformity, with an increased anteroposter-
ior diameter, decreased biparietal diameter and reduced
cephalic index (<76%) In contrast, non-scaphocephalic sa-
gittal synostosis is a rare diagnosis [25]. In the first
reported cases of non-scaphocephalic sagittal synostosis
only eight patients were identified out of 193 patients with
isolated sagittal synostosis [25]. It is interesting to note that
a diagnosis of raised ICP was made in 66% of these non-
scaphocephalic cases, much higher than the reported inci-
dence of 14% for all single suture synostosis [11].
An underlying genetic defect has recently been identi-
fied in Frank-ter Haar syndrome following homozygosity
mapping in 16 patients from 12 affected families [7].
The mutated gene, SH3PXD2B on chromosome 5q35.1,
encodes tyrosine kinase substrate with four Src hom-
ology 3 [SH3] domains (TKS4), a protein considered in-
tegral to the formation and functioning of podosomes.
These are cell membrane protrusions which facilitate
cell adhesion, migration, and extracellular matrixdegradation [7]. Two mouse models with Sh3pxd2b loss
of function mutations have been described. The first is a
spontaneous nee mutation resulting from the deletion of a
single base pair in exon 13 of the Sh3pxd2b gene
(1303delA), which is thought to encode a truncated pro-
tein lacking part of the third and all of the fourth SH3
domains [16,26]. The second is an engineered null muta-
tion created by the insertion of a gene trap vector between
exons 3 and 4 of the Sh3pxd2b gene, which appears to re-
sult in a complete loss of gene expression [7]. Mice with
the engineered null mutation appear to share many of the
craniofacial, skeletal and cardiac features described in
patients with Frank-ter Haar syndrome including mitral
valve defects, hypertelorism and micrognathia [7,26,27].
Significantly, abnormal cranial proportions were
described in these Sh3pxd2b null mice, which had a short
snout, brachycephaly and hypertelorism, associated with
persistently open sagittal sutures [7]. Both Sh3pxd2b null
and Sh3pxd2b nee mice appear to develop ocular fea-
tures including corneal opacities and anterior segment
dysgenesis resulting in early-onset glaucoma. Sh3pxd2b
nee mice also have abnormal craniofacial features in-
cluding a short snout, brachycephalic skull, and Eusta-
chian tube dysmorphology [16,26,27]. Surprisingly the
ocular features associated with Frank-ter Haar syndrome
were not identified in any of the three affected siblings,
which contrasts both with the occurrence of megalcor-
nea in all previous patients with identified SH3PXD2B
mutations and with the ocular abnormalities described
in both mouse models.
A variety of specific SH3PXD2B gene mutations have
been reported in families with the Frank-ter Haar syn-
drome phenotype, but none so far have reported specific
involvement of exon 13, the region of the gene affected in
this family (Figure 3). However deletion of the entire
SH3PXD2B gene has been described in one family [7]. Our
three children have many features classically associated
with Frank-ter Haar syndrome however they also have
additional features which to our knowledge have not been
described in previous reports (Table 1). These include lym-
phoedema, class III malocclusion, anterior open bite, open
metopic suture, and non-scaphocephalic sagittal synostosis.
Although we cannot completely exclude the possibility that
these novel phenotypes are related to the two other regions
of shared homozygosity identified on chromosomes 8 and
12 in this family, the involvement of the sagittal suture and
additional craniofacial features in mouse models of the dis-
ease provides a precedent. The clinical features of craniosy-
nostosis and raised ICP in this family therefore expand the
clinical spectrum of Frank-ter Haar syndrome.
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